An Observational Study of Distress Immune Function and Pain in HIV.

  • STATUS
    Recruiting
  • days left to enroll
    22
  • participants needed
    100
  • sponsor
    University of Cape Town
Updated on 10 October 2021
HIV Vaccine

Summary

This case-control study focuses on pain in HIV, which is common despite antiretroviral therapy and compromises quality of life, mental health and daily functioning. Specifically, it will investigate the relationships between psychosocial distress, inflammation and pain in HIV.

Description

We plan to recruit 100 people and follow them for 6 months, taking repeated measures. Participants who report persistent pain at enrolment will be assessed at 0 (baseline), 2, 4, and 6 months. Participants who report no pain at enrolment will be assessed at 0 (baseline) and 6 months. All participants will also be invited to participate in weekly remote assessment of selected self-reported outcomes.

Details
Condition HIV, HIV positive, HIV infection, AIDS Vaccines, Pain, Chronic Pain, Post-Surgical Pain, Immune System and Related Disorders, Pain (Pediatric), HIV (Pediatric), Central Sensitization, Central Sensitisation, HIV Infections, human immunodeficiency virus, hiv disease, HIV Vaccine, hiv vaccines, chronic pains, Distress, Emotional, Distress, Emotional, Distress, Emotional, Distress, Emotional
Treatment Pain
Clinical Study IdentifierNCT04757987
SponsorUniversity of Cape Town
Last Modified on10 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

HIV-positive with viral suppression
report either persistent pain or no pain at enrolment

Exclusion Criteria

pregnancy
acute psychiatric condition requiring urgent care
cognitive impairment preventing full participation
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note